TRIAMTERENE AND HYDROCHLOROTHIAZIDE
- Product NDC
- 61919-338
- 11-digit product format
- 619190338
- Labeler code
- 61919
- Product ID
- 61919-338_c80d15e2-fc5c-8d53-e053-2a95a90a8d67
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- TRIAMTERENE AND HYDROCHLOROTHIAZIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- DirectRX
- Application
- ANDA071251
- Marketing category
- ANDA
- Marketing start
- 2015-12-01
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE; TRIAMTERENE
- Active strength
- 25 mg/1; mg/1
- Pharmacologic classes
- Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS],Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-338-30 | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | 30 in 1 BOTTLE | TABLET | 30 | | 4 |
| 61919-338-90 | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | 90 in 1 BOTTLE | TABLET | 90 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-338 | TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [DIRECTRX] | 4 | Legacy NDC, 2 package rows | 20210727_25dc3437-0042-74a1-e054-00144ff88e88.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-338-30 | 61919033830 | 30 TABLET in 1 BOTTLE (61919-338-30) | 30 tablet | 2015-12-01 | 0000-00-00 | No | No | Current |
| 61919-338-90 | 61919033890 | 90 TABLET in 1 BOTTLE (61919-338-90) | 90 tablet | 2015-12-01 | 0000-00-00 | No | No | Current |